Odyssey Health (ODYY) Cash from Operations (QoQ) (2015 - 2026)
Odyssey Health (ODYY) Cash from Operations (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -12.05% |
| Jan 31, 2026 | -0.09% |
| Oct 31, 2025 | -489.22% |
| Jul 31, 2025 | -1,104.67% |
| Apr 30, 2025 | 91.43% |
| Jan 31, 2025 | 81.22% |
| Oct 31, 2024 | -290.53% |
| Jul 31, 2024 | 65.44% |
| Apr 30, 2024 | 79.71% |
| Jan 31, 2024 | -1,414.91% |
| Oct 31, 2023 | 50.01% |
| Jul 31, 2023 | 27.91% |
| Apr 30, 2023 | 81.61% |
| Jan 31, 2023 | -217.48% |
| Oct 31, 2022 | -126.36% |
| Jul 31, 2022 | 211.35% |
| Apr 30, 2022 | -131.19% |
| Jan 31, 2022 | 63.99% |
| Oct 31, 2021 | -63.07% |
| Jul 31, 2021 | 61.31% |